Header Logo

Connection

Nicholas Hanna to Humans

This is a "connection" page, showing publications Nicholas Hanna has written about Humans.
Connection Strength

0.221
  1. Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention. J Interv Cardiol. 2011 Jun; 24(3):278-84.
    View in: PubMed
    Score: 0.021
  2. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2010 Aug 15; 106(4):504-10.
    View in: PubMed
    Score: 0.020
  3. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes. Circ Cardiovasc Interv. 2023 May; 16(5):e012655.
    View in: PubMed
    Score: 0.012
  4. Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study. EuroIntervention. 2022 Aug 05; 18(5):e407-e416.
    View in: PubMed
    Score: 0.012
  5. Balloon-Expandable Valve Geometry After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid Versus Tricuspid Aortic Stenosis. Cardiovasc Revasc Med. 2021 12; 33:7-12.
    View in: PubMed
    Score: 0.011
  6. Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial. Am Heart J. 2021 07; 237:25-33.
    View in: PubMed
    Score: 0.011
  7. Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients. Circ Cardiovasc Interv. 2021 01; 14(1):e009983.
    View in: PubMed
    Score: 0.010
  8. Anatomical Characteristics Associated With Hypoattenuated Leaflet Thickening in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021 06; 27:1-6.
    View in: PubMed
    Score: 0.010
  9. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020 03 23; 13(6):726-735.
    View in: PubMed
    Score: 0.010
  10. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis. JACC Cardiovasc Interv. 2020 05 11; 13(9):1019-1027.
    View in: PubMed
    Score: 0.010
  11. Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 04 15; 125(8):1216-1221.
    View in: PubMed
    Score: 0.010
  12. Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Circ Cardiovasc Imaging. 2019 12; 12(12):e009608.
    View in: PubMed
    Score: 0.010
  13. TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial. JACC Cardiovasc Interv. 2019 05 27; 12(10):901-907.
    View in: PubMed
    Score: 0.009
  14. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2018 10 30; 72(18):2095-2105.
    View in: PubMed
    Score: 0.009
  15. Endovascular recanalization of central venous access to allow for pacemaker implantation or upgrade. Cardiovasc Revasc Med. 2012 Jul-Aug; 13(4):215-8.
    View in: PubMed
    Score: 0.006
  16. Reliability of prehospital real-time cellular video phone in assessing the simplified National Institutes Of Health Stroke Scale in patients with acute stroke: a novel telemedicine technology. Stroke. 2011 Jun; 42(6):1522-7.
    View in: PubMed
    Score: 0.005
  17. Cellular video-phone assisted transmission and interpretation of prehospital 12-lead electrocardiogram in acute st-segment elevation myocardial infarction. J Interv Cardiol. 2011 Apr; 24(2):112-8.
    View in: PubMed
    Score: 0.005
  18. Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention. Am J Cardiol. 2010 Oct 15; 106(8):1069-74.
    View in: PubMed
    Score: 0.005
  19. Does on- versus off-hours presentation impact in-hospital outcomes of ST-segment elevation myocardial infarction patients transferred to a tertiary care center? Catheter Cardiovasc Interv. 2010 Oct 01; 76(4):484-90.
    View in: PubMed
    Score: 0.005
  20. A novel percutaneous coronary intervention risk score to predict one-year mortality. Am J Cardiol. 2010 Sep 01; 106(5):641-5.
    View in: PubMed
    Score: 0.005
  21. Insurance type influences the use of drug-eluting stents. JACC Cardiovasc Interv. 2010 Jul; 3(7):773-9.
    View in: PubMed
    Score: 0.005
  22. Utility of radiologic review for noncardiac findings on multislice computed tomography in patients with severe aortic stenosis evaluated for transcatheter aortic valve implantation. Am J Cardiol. 2010 May 15; 105(10):1461-4.
    View in: PubMed
    Score: 0.005
  23. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes. Am J Cardiol. 2010 Mar 15; 105(6):833-8.
    View in: PubMed
    Score: 0.005
  24. A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease! Catheter Cardiovasc Interv. 2010 Feb 01; 75(2):195-201.
    View in: PubMed
    Score: 0.005
  25. Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era. Am J Cardiol. 2009 Apr 01; 103(7):950-3.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.